(Q79662869)

English

Outcomes of patients with prostate cancer receiving zoledronic acid or pamidronate for prevention of skeletal-related events

scientific article published on 01 February 2007

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17253911

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253911%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 December 2019

title

Outcomes of patients with prostate cancer receiving zoledronic acid or pamidronate for prevention of skeletal-related events (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17253911

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253911%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

Jeffrey T Sherer

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17253911

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253911%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 December 2019

Andrea T Adamus

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17253911

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253911%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 December 2019

publication date

1 February 2007

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17253911

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253911%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

17253911

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253911%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 December 2019

volume

27

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17253911

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253911%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 December 2019

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17253911

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253911%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 December 2019

page(s)

207-217

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17253911

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253911%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 December 2019

Identifiers

DOI

10.1592/PHCO.27.2.207

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17253911

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253911%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 December 2019

PubMed publication ID

17253911

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17253911

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253911%20AND%20SRC:MED&resulttype=core&format=json

(Q79662869)

Outcomes of patients with prostate cancer receiving zoledronic acid or pamidronate for prevention of skeletal-related events

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)